SPL $3.7M R&D Tax Incentive Received 28/08/25 PRICE SENSITIVE download Created with Sketch. 123.28KB Share SPL FY25 Key Financial Results and Annual Report 26/08/25 PRICE SENSITIVE download Created with Sketch. 595.7KB Share SPL 2025 Appendix 4E Preliminary Financial Report 26/08/25 PRICE SENSITIVE download Created with Sketch. 157.44KB Share SPL Quarterly Activities/Appendix 4C Cash Flow Report 31/07/25 PRICE SENSITIVE download Created with Sketch. 698.06KB Share SPL Quarterly Activities/Appendix 4C Cash Flow Report 30/04/25 PRICE SENSITIVE download Created with Sketch. 686.07KB Share SPL Half Yearly Report and Accounts 26/02/25 PRICE SENSITIVE download Created with Sketch. 2.38MB Share SPL Quarterly Activities/Appendix 4C Cash Flow Report 29/01/25 PRICE SENSITIVE download Created with Sketch. 271.62KB Share SPL SPL receives positive FDA feedback on DEP SN38 for PROC 19/12/24 PRICE SENSITIVE download Created with Sketch. 166.7KB Share SPL AGM Chair's address and CEO's presentation 26/11/24 PRICE SENSITIVE download Created with Sketch. 2.35MB Share SPL Quarterly Activities/Appendix 4C Cash Flow Report 31/10/24 PRICE SENSITIVE download Created with Sketch. 617.17KB Share SPL SPL7013 Nasal Spray Australia Update 18/10/24 PRICE SENSITIVE download Created with Sketch. 158.47KB Share SPL Starpharma Receives $5.5M R&D Tax Incentive Refund 12/09/24 PRICE SENSITIVE download Created with Sketch. 129.24KB Share SPL Annual Report to shareholders 22/08/24 PRICE SENSITIVE download Created with Sketch. 14.97MB Share SPL Quarterly Activities/Appendix 4C Cash Flow Report 30/07/24 PRICE SENSITIVE download Created with Sketch. 628.88KB Share SPL Positive final DEP irinotecan Phase 2 clinical trial results 27/05/24 PRICE SENSITIVE download Created with Sketch. 231.8KB Share SPL Starpharma Business Update 22/05/24 PRICE SENSITIVE download Created with Sketch. 1.8MB Share SPL Quarterly Activities/Appendix 4C Cash Flow Report 30/04/24 PRICE SENSITIVE download Created with Sketch. 341.27KB Share SPL Starpharma and Medicxi Partnership Petalion Therapeutics 08/04/24 PRICE SENSITIVE download Created with Sketch. 190.59KB Share SPL S&P DJI Announces March 2024 Quarterly Rebalance 01/03/24 PRICE SENSITIVE download Created with Sketch. 120.24KB Share SPL Half Yearly Report and Accounts 28/02/24 PRICE SENSITIVE download Created with Sketch. 1.33MB Share SPL VivaGel BV US FDA Appeal Outcome 19/02/24 PRICE SENSITIVE download Created with Sketch. 209.89KB Share SPL Quarterly Activities/Appendix 4C Cash Flow Report 31/01/24 PRICE SENSITIVE download Created with Sketch. 344.69KB Share SPL Viraleze shows antiviral efficacy in COVID-19 patients 29/01/24 PRICE SENSITIVE download Created with Sketch. 302KB Share SPL VivaGel BV sales and distribution agreement MENA region 22/01/24 PRICE SENSITIVE download Created with Sketch. 238.74KB Share SPL Positive DEP docetaxel Phase 2 results 19/12/23 PRICE SENSITIVE download Created with Sketch. 303.21KB Share SPL AGM Chairman's address and CEO presentation 29/11/23 PRICE SENSITIVE download Created with Sketch. 7.75MB Share SPL Starpharma announces new CEO, Ms Cheryl Maley 10/11/23 PRICE SENSITIVE download Created with Sketch. 238.8KB Share SPL Quarterly Activities/Appendix 4C Cash Flow Report 31/10/23 PRICE SENSITIVE download Created with Sketch. 722.62KB Share SPL Starpharma receives $7.2 million R&D Tax Incentive refund 23/10/23 PRICE SENSITIVE download Created with Sketch. 195.31KB Share SPL Positive DEP Cabazitaxel Phase 2 Results in Multiple Cancer 18/10/23 PRICE SENSITIVE download Created with Sketch. 386.76KB Share SPL DEP irinotecan clinical data presented at AACR meeting 16/10/23 PRICE SENSITIVE download Created with Sketch. 1.59MB Share SPL DEP irinotecan combination data presentation 27/09/23 PRICE SENSITIVE download Created with Sketch. 244.62KB Share SPL VIRALEZ UK COVID-19 Clinical Study Completes Recruitment 25/09/23 PRICE SENSITIVE download Created with Sketch. 211KB Share SPL Positive DEP irinotecan clinical results presentation 13/09/23 PRICE SENSITIVE download Created with Sketch. 305.62KB Share SPL App 4E/Annual Report to shareholders 24/08/23 PRICE SENSITIVE download Created with Sketch. 4.53MB Share SPL SPL to receive $6.5M from Mundipharma and VivaGel BV rights 14/08/23 PRICE SENSITIVE download Created with Sketch. 200.3KB Share SPL Partnered Program Update 31/07/23 PRICE SENSITIVE download Created with Sketch. 217.74KB Share SPL Quarterly Activities/Appendix 4C Cash Flow Report 31/07/23 PRICE SENSITIVE download Created with Sketch. 731.65KB Share SPL Trading Halt 28/07/23 PRICE SENSITIVE download Created with Sketch. 218.36KB Share SPL Pause in Trading 28/07/23 PRICE SENSITIVE download Created with Sketch. 114.3KB Share SPL Starpharma partners with UQ to advance DEP radio pipeline 26/07/23 PRICE SENSITIVE download Created with Sketch. 216.87KB Share SPL DEP HER2-radiodiagnostic shows imaging benefits 21/07/23 PRICE SENSITIVE download Created with Sketch. 293.92KB Share SPL Clinical Trial Update 27/06/23 PRICE SENSITIVE download Created with Sketch. 213.03KB Share SPL Starpharma CEO to retire in 2024 09/06/23 PRICE SENSITIVE download Created with Sketch. 178.72KB Share SPL VIRALEZE Nasal Spray Approved in Malaysia 05/06/23 PRICE SENSITIVE download Created with Sketch. 225.85KB Share SPL Quarterly Activities/Appendix 4C Cash Flow Report 28/04/23 PRICE SENSITIVE download Created with Sketch. 401.33KB Share SPL HER2-targeted DEP SN38 ADC outperforms in HER2 cancer model 26/04/23 PRICE SENSITIVE download Created with Sketch. 302.96KB Share SPL Interim Report and Half-Year Financial Results 28/02/23 PRICE SENSITIVE download Created with Sketch. 1.2MB Share SPL Quarterly Activities Report & Appendix 4C 30/01/23 PRICE SENSITIVE download Created with Sketch. 329.34KB Share SPL Response to ASX Query Letters 12/01/23 PRICE SENSITIVE download Created with Sketch. 504.84KB Share SPL Starpharma receives $7.1M R&D tax incentive refund 23/12/22 PRICE SENSITIVE download Created with Sketch. 200.28KB Share SPL VIRALEZE Nasal Spray Registered in Indonesia 14/12/22 PRICE SENSITIVE download Created with Sketch. 229.62KB Share SPL Positive AZD0466 clinical data presented by AstraZeneca 13/12/22 PRICE SENSITIVE download Created with Sketch. 258.89KB Share SPL AGM Chairman address and CEO presentation 29/11/22 PRICE SENSITIVE download Created with Sketch. 7.66MB Share SPL Quarterly Activities Report & Appendix 4C 26/10/22 PRICE SENSITIVE download Created with Sketch. 379.1KB Share SPL VIRALEZE distribution agreement for Hong Kong and Macau 21/10/22 PRICE SENSITIVE download Created with Sketch. 197.81KB Share SPL New clinical data for DEP cabazitaxel in prostate cancer 12/09/22 PRICE SENSITIVE download Created with Sketch. 307.37KB Share SPL S&P DJI Announces September 2022 Quarterly Rebalance 02/09/22 PRICE SENSITIVE download Created with Sketch. 134KB Share SPL Starpharma annual report and full year financial results 25/08/22 PRICE SENSITIVE download Created with Sketch. 7.93MB Share SPL Starpharma signs new DEP agreement with MSD 10/08/22 PRICE SENSITIVE download Created with Sketch. 184.49KB Share SPL Quarterly Activities Report & Appendix 4C 29/07/22 PRICE SENSITIVE download Created with Sketch. 363.61KB Share SPL VIRALEZE Protects Against Omicron in Viral Challenge Model 20/07/22 PRICE SENSITIVE download Created with Sketch. 328.62KB Share SPL VIRALEZE relaunched by LloydsPharmacy in the UK 30/06/22 PRICE SENSITIVE download Created with Sketch. 192.04KB Share SPL SPL signs expanded DEP research agreement with US Biopharma 27/06/22 PRICE SENSITIVE download Created with Sketch. 194.04KB Share SPL SPL7013 in VIRALEZE virucidal against influenza A and B 18/05/22 PRICE SENSITIVE download Created with Sketch. 281.77KB Share SPL Quarterly Cashflow and Activities Report 29/04/22 PRICE SENSITIVE download Created with Sketch. 357.52KB Share SPL VIRALEZE to relaunch in the UK 01/04/22 PRICE SENSITIVE download Created with Sketch. 257.72KB Share SPL SPL7013 in VIRALEZE virucidal against Omicron 01/03/22 PRICE SENSITIVE download Created with Sketch. 333.51KB Share SPL Interim Report and Half-Year Financial Results 21/02/22 PRICE SENSITIVE download Created with Sketch. 1016.82KB Share SPL VIRALEZE sales and distribution in Saudi Arabia and GCC 03/02/22 PRICE SENSITIVE download Created with Sketch. 273.05KB Share SPL Quarterly Cashflow and Activities Report 28/01/22 PRICE SENSITIVE download Created with Sketch. 693.79KB Share SPL Starpharma receives $7.7M R&D tax incentive refund 20/01/22 PRICE SENSITIVE download Created with Sketch. 215.29KB Share SPL VIRALEZE successfully launched in Vietnam 13/12/21 PRICE SENSITIVE download Created with Sketch. 214.71KB Share SPL Starpharma signs DEP Research Agreement with US Biopharma Co 07/12/21 PRICE SENSITIVE download Created with Sketch. 201.34KB Share SPL VIRALEZE distribution agreement and launch in Vietnam 03/12/21 PRICE SENSITIVE download Created with Sketch. 223.84KB Share SPL VIRALEZE registered in Vietnam with launch this week 01/12/21 PRICE SENSITIVE download Created with Sketch. 213.23KB Share SPL AGM Chairman address and CEO presentation 30/11/21 PRICE SENSITIVE download Created with Sketch. 9.34MB Share SPL Positive DEP phase 2 interim results in prostate cancer 25/11/21 PRICE SENSITIVE download Created with Sketch. 325.01KB Share SPL Quarterly Cashflow and Activities Report 29/10/21 PRICE SENSITIVE download Created with Sketch. 520.01KB Share SPL VIRALEZE distribution and supply to Vietnam 26/10/21 PRICE SENSITIVE download Created with Sketch. 223.97KB Share SPL VIRALEZE launch in ADMENTA Italia Group pharmacies in Italy 08/10/21 PRICE SENSITIVE download Created with Sketch. 434.53KB Share SPL Starpharma annual report and full year financial results 26/08/21 PRICE SENSITIVE download Created with Sketch. 4.97MB Share SPL VIRALEZE Protects Against SARS-CoV-2 in Challenge Model 23/08/21 PRICE SENSITIVE download Created with Sketch. 346.96KB Share SPL VIRALEZE well tolerated in multiple dose clinical study 17/08/21 PRICE SENSITIVE download Created with Sketch. 218.14KB Share SPL Quarterly Cashflow and Activities Report 30/07/21 PRICE SENSITIVE download Created with Sketch. 458.77KB Share SPL VIRALEZE SPL7013 virucidal against SARS-CoV-2 Delta variant 27/07/21 PRICE SENSITIVE download Created with Sketch. 293.54KB Share SPL VIRALEZE UK Update 21/06/21 PRICE SENSITIVE download Created with Sketch. 189.86KB Share SPL VIRALEZE SPL7013 virucidal against multiple COVID variants 18/06/21 PRICE SENSITIVE download Created with Sketch. 489.28KB Share SPL VIRALEZE antiviral nasal spray registered for sale in India 11/06/21 PRICE SENSITIVE download Created with Sketch. 271.42KB Share SPL VIRALEZE SPL7013 highly active in UK variant of coronavirus 01/06/21 PRICE SENSITIVE download Created with Sketch. 506.94KB Share SPL VIRALEZE launches in Europe 06/05/21 PRICE SENSITIVE download Created with Sketch. 218.14KB Share SPL Quarterly Cashflow and Activities Report 27/04/21 PRICE SENSITIVE download Created with Sketch. 296.53KB Share SPL VIRALEZE to be launched with LloydsPharmacy in the UK 25/03/21 PRICE SENSITIVE download Created with Sketch. 240.28KB Share SPL DEP HER2-lutetium outperforms in human breast cancer model 16/03/21 PRICE SENSITIVE download Created with Sketch. 252.17KB Share SPL Interim Report and Half-Year Financial Results 25/02/21 PRICE SENSITIVE download Created with Sketch. 1.36MB Share SPL VIRALEZE antiviral nasal spray registered in Europe 23/02/21 PRICE SENSITIVE download Created with Sketch. 225.86KB Share SPL Starpharma signs DEP ADC Research Agreement with MSD 12/02/21 PRICE SENSITIVE download Created with Sketch. 171.94KB Share SPL AZD0466 clinical DEP program global expansion 09/02/21 PRICE SENSITIVE download Created with Sketch. 58.71KB Share SPL Quarterly Cashflow and Activities Report 29/01/21 PRICE SENSITIVE download Created with Sketch. 102.2KB Share SPL VIRALEZE COVID-19 nasal spray study to commence in January 22/12/20 PRICE SENSITIVE download Created with Sketch. 70.54KB Share
